No Data
AstraZeneca Earnings Expected to Rise With Focus on China -- Earnings Preview
Report Says 25% Pharma Tariff Would Raise US Drug Prices by $51 Billion Annually, Reuters Reports
Earnings Week Ahead: MSFT, AAPL, META, AMZN, QCOM, PFE, MA, V, PYPL, ROKU, MCD, SBUX, KO, and More
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, IRhythm Technologies and SOPHiA GENETICS
Onco-Innovations' Inka Health Signs New Analytical Work With AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
